KMDA · Kamada Ltd · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-09 | Tsur David |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 9, 2026. |
Ordinary Shares
|
175 |
| 2026-09-08 | Tsur David |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 8, 2026. |
Ordinary Shares
|
162,760 |
| 2026-09-07 | Tsur David |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 7, 2026. |
Ordinary Shares
|
14,238 |
| 2026-09-02 | Tsur David |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.53. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
26,500 |
| 2026-09-02 | Tsur David |
Director |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. |
Ordinary Shares
|
22,500 |
| 2026-09-02 | Tsur David |
Director |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
22,500 |
| 2026-09-02 | Tsur David |
Director |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.53. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. |
Ordinary Shares
|
26,500 |
| 2026-09-02 | Brenner Yael |
VP Quality |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. This option was previously reported as covering 3,036 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. |
Ordinary Shares
|
3,036 |
| 2026-09-02 | Brenner Yael |
VP Quality |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. This option was previously reported as covering 3,036 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026. Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
3,036 |
| 2026-09-02 | Tsur David |
Director |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents a "net exercise" of outstanding stock options. The reporting person received 6,406 ordinary shares on net exercise of option to purchase 22,500 ordinary shares. The Company withheld 16,094 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.26, pursuant to the terms of the Company's 2011 Share Award Plan. All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. |
Ordinary Shares
|
6,406 |
| 2026-09-02 | Brenner Yael |
VP Quality |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents a "net exercise" of outstanding stock options. The reporting person received 865 ordinary shares on net exercise of option to purchase 3,036 ordinary shares. The Company withheld 2,171 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.37, pursuant to the terms of the Company's 2011 Share Award Plan. All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. |
Ordinary Shares
|
865 |
| 2026-09-02 | Tsur David |
Director |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents a "net exercise" of outstanding stock options. The reporting person received 2,760 ordinary shares on net exercise of option to purchase 26,500 ordinary shares. The Company withheld 23,740 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.30, pursuant to the terms of the Company's 2011 Share Award Plan. All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026. |
Ordinary Shares
|
2,760 |
| 2026-08-26 | Brenner Yael |
VP Quality |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026. Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
10,000 |
| 2026-08-26 | Brenner Yael |
VP Quality |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026. Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
10,000 |
| 2026-08-26 | Brenner Yael |
VP Quality |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026. |
Ordinary Shares
|
10,000 |
| 2026-08-26 | Brenner Yael |
VP Quality |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026. |
Ordinary Shares
|
10,000 |
| 2026-08-26 | Brenner Yael |
VP Quality |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026. |
Ordinary Shares
|
10,000 |
| 2026-08-26 | Brenner Yael |
VP Quality |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents a "net exercise" of outstanding stock options. The reporting person received 2,776 ordinary shares on net exercise of option to purchase 10,000 ordinary shares. The Company withheld 7,224 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on August 26, 2026 of $8.58, pursuant to the terms of the Company's 2011 Share Award Plan. All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026. |
Ordinary Shares
|
2,776 |
| 2026-08-26 | Brenner Yael |
VP Quality |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026. Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
10,000 |
| 2026-08-26 | Brenner Yael |
VP Quality |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents a "net exercise" of outstanding stock options. The reporting person received 2,776 ordinary shares on net exercise of option to purchase 10,000 ordinary shares. The Company withheld 7,224 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on August 26, 2026 of $8.58, pursuant to the terms of the Company's 2011 Share Award Plan. All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026. |
Ordinary Shares
|
2,776 |
| 2026-08-26 | Brenner Yael |
VP Quality |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents a "net exercise" of outstanding stock options. The reporting person received 2,776 ordinary shares on net exercise of option to purchase 10,000 ordinary shares. The Company withheld 7,224 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on August 26, 2026 of $8.58, pursuant to the terms of the Company's 2011 Share Award Plan. All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026. |
Ordinary Shares
|
2,776 |
| 2026-08-05 | Asher-Topilsky Lilach |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
30,000 |
| 2026-08-05 | Payorski Lilach |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
30,000 |
| 2026-08-05 | RECANATI LEON |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
30,000 |
| 2026-08-05 | ITSHAYEK ASSAF |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
30,000 |
| 2026-08-05 | Tsur David |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
30,000 |
| 2026-08-05 | Botzer Uri |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
30,000 |
| 2026-08-05 | DAVIDI ISHAY |
Director, 10% Owner |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
30,000 |
| 2026-08-05 | Dekel Benjamin |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
30,000 |
| 2026-08-05 | Goldwasser Karnit |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
30,000 |
| 2026-04-07 | ORLEV CHAIME |
Chief Financial Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. |
Employee Stock Option (right to buy)
(I)
|
22,500 |
| 2026-04-07 | Tsur David |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
7,500 |
| 2026-04-07 | DAVIDI ISHAY |
Director, 10% Owner |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
7,500 |
| 2026-04-07 | Dekel Benjamin |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
4,000 |
| 2026-04-07 | Nir Eran |
Vice President, Operations |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
22,500 |
| 2026-04-07 | DAVIDI ISHAY |
Director, 10% Owner |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
6,625 |
| 2026-04-07 | Reshef Liron |
VP Human Resources |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
15,000 |
| 2026-04-07 | Livneh Nir |
VP, General Counsel |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
15,000 |
| 2026-04-07 | Reshef Liron |
VP Human Resources |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
10,000 |
| 2026-04-07 | ORLEV CHAIME |
Chief Financial Officer |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. |
Employee Stock Option (right to buy)
(I)
|
22,500 |
| 2026-04-07 | Neheman Hanni |
VP, Marketing & Sales |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
15,000 |
| 2026-04-07 | DAVIDI ISHAY |
Director, 10% Owner |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
7,500 |
| 2026-04-07 | Beladev Shavit |
VP Plasma Operations |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
15,000 |
| 2026-04-07 | Brenner Yael |
VP Quality |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
15,000 |
| 2026-04-07 | Brenner Yael |
VP Quality |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
15,000 |
| 2026-04-07 | DAVIDI ISHAY |
Director, 10% Owner |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
7,500 |
| 2026-04-07 | Pinchuk Orit |
VP Regulatory Affairs |
Other↓
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
15,000 |
| 2026-04-07 | Pinchuk Orit |
VP Regulatory Affairs |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
15,000 |
| 2026-04-07 | ORLEV CHAIME |
Chief Financial Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. |
Employee Stock Option (right to buy)
(I)
|
22,500 |
| 2026-04-07 | Goldwasser Karnit |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Indirect)
All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026. The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant. Held by trustee under the Company's 2011 Share Award Plan. |
Employee Stock Option (right to buy)
(I)
|
6,625 |